LISA SWOFFORD: Open Payments
NPI 1083667448 · COLQUITT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 14 payments from 8 companies in 2025. Trend: 2023 $347 · 2024 $404 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $119 |
| ABBVIE INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Rybelsus, Wegovy, Ozempic, VRAYLAR, TRELEGY ELLIPTA, AIRSUPRA, Dexcom G6 Transmitter, TRUMENBA.
Industry payments across GA — which companies pay providers there.
